Replies to post #691862 on NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

I'm not losing sleep over it but any normal shareholder who still has any skin left in the game should be...At least you'd think. ??

It’s in my risk assessment. But not enough to lose sleep over.

I’ve read everything that is publicly available on the MSA and have found nothing out of the ordinary for how the contracts are set up. And I remind you my background is heavily in contract manufacturing.

Cost+ with a minimum take or pay is wildly common, and that’s exactly how this is set up.

I’m guessing, but it looks like since volumes are currently under the take or pay minimum LP is letting Advent do the billing to realize those revenues rather than putting it on NWBO’s books. The intricacies of those tax details are not my area of expertise though. This could be a swing and miss on my part, and it’s even harder to know without seeing the detailed contract.

I’m sure the contract details that we are not privy to will be restructured upon commercialization but we aren’t at that point.

So yes, while I see the risk you are alluding to, it doesn’t measure as substantial in my DD.